Výsledky vyhledávání - "V, Nadipelli"

Cost-Effectiveness of Enoxaparin as Thromboprophylaxis in Acutely Ill Medical Patients in Spain

Autor: V Nadipelli, C. Rubio-Terrés, C. Suarez, J Kosa, F. Antoñanzas Villar, Mjc Nuijten

Publikováno v: Value in Health. 6:126-136

Objective The objective of this study was to determine the cost-effectiveness of thromboprophylaxis with enoxaparin versus no thromboprophylaxis in patients with acute medical illness in Spain from the society perspective. Methods Markov process anal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1aad5e7d10e96a4e43bcd7e08f582c70
https://doi.org/10.1046/j.1524-4733.2003.00210.x

Zobrazit plný text záznamu

Relapse In Opioid Use Disorder: Implications For Health Care Utilization And Costs

Autor: Charles Ruetsch, Hyong Un, B Brady, Naoko A Ronquest, J Volpicelli, V Nadipelli, Joseph Tkacz

Publikováno v: Value in Health. 19:A188

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::84db8695a077dbc8e36362ffe3ca3ddc
https://doi.org/10.1016/j.jval.2016.03.1375

Zobrazit plný text záznamu

The Association Between Buprenorphine Medication-Assisted Treatment Adherence And Health Care Service Utilization And Costs

Autor: V Nadipelli, Hyong Un, B Brady, J Volpicelli, Naoko A Ronquest, Charles Ruetsch, Joseph Tkacz

Publikováno v: Value in Health. 19:A187

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9be8962fea4ea2a7ecbd6599fc453e6b
https://doi.org/10.1016/j.jval.2016.03.1371

Zobrazit plný text záznamu

[Cost-effectiveness analysis of enoxaparin for the prophylaxis of venous thromboembolism in major orthopedic surgery patients]

Autor: M, Brosa Riestra, C, Rubio-Terrés, V, Nadipelli, A, Casado Collado, F, Martínez Brotons

Publikováno v: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 27(4)

A retrospective, modeled, cost-effectiveness analysis was conducted with enoxaparin versus non-prophylaxis, tinzaparin, and unfractionated heparin for venous thromboembolic disease in Spanish patients undergoing major orthopedic surgery from the stan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::09016d6764f61108820f9c48b501eb3c
https://pubmed.ncbi.nlm.nih.gov/12966450

Zobrazit plný text záznamu

Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States

Autor: Joseph A. Caprini, Christopher F. Bell, Alexander T. Cohen, Chris L. Pashos, Marc F. Botteman, V Nadipelli, Jennifer M. Stephens

Publikováno v: Clinical therapeutics. 24(11)

Background: Premature death due to pulmonary embolism is a short-term complication of deep vein thrombosis (DVT). The long-term clinical course after DVT can be further complicated by excess mortality, recurrent venous thromboembolism (VTE), and the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf8522626906f53844e557f61f2d8060
https://pubmed.ncbi.nlm.nih.gov/12501885

Zobrazit plný text záznamu

Cost-effectiveness analysis of enoxaparin versus unfractionated heparin in the secondary prevention of acute coronary syndrome

Autor: Carlos Rubio-Terrés, Max Brosa, Jenaro Froufe, Ibrahim Farr, V Nadipelli

Publikováno v: PharmacoEconomics. 20(14)

Background: The Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) and Thrombolysis in Myocardial Infarction (TIMI) 11B studies revealed that enoxaparin reduced the incidence of death, myocardial reinfarction and r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae73aae42e07667773affee7bdcdb660
https://pubmed.ncbi.nlm.nih.gov/12403638

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání